December 11, 2023 – Page 6

With 9.7% CAGR, Sterilization Equipment Market Size to Surpass USD 19.25 Billion by 2030

Written by Customer Service on December 11, 2023. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the global Sterilization Equipment Market size is projected to reach USD 19.25 billion in 2030, at a CAGR of 9.7% during the forecast period, 2023-2030 Sterilization Equipment Market Forecast 2023-2030 Pune, India, Dec. 11, 2023 (GLOBE NEWSWIRE) — Global Sterilization Equipment Market Size was valued at USD 9.31 billion in 2022 and is projected to grow from USD 19.25 billion by 2030 exhibiting a CAGR of 9.7% during the forecast period. North American Market Ruled the Market Owing to Rising Healthcare Spending, Increasing Incidence of HAIs to Spur Market Growth Sterilization equipment is used for decontaminating equipment used in healthcare facilities. The market’s growth can be attributed to the increased awareness and emphasis on infection control in healthcare settings, driven...

Treatment-Resistant Depression Treatment Market Size, Share & Growth Analysis, [2030] | With CAGR of 11.0%

Written by Customer Service on December 11, 2023. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the global treatment-resistant depression treatment market size is projected to reach USD 4.06 billion in 2030, at a CAGR of 11.0% during the forecast period, 2023-2030 Treatment-Resistant Depression Treatment Market Treatment-Resistant Depression Treatment Market Forecasts, 2023-2030 Pune, India, Dec. 11, 2023 (GLOBE NEWSWIRE) — The treatment-resistant depression treatment market size is projected to grow from USD 1.95 billion in 2023 to USD 4.06 billion by 2030, exhibiting a CAGR of 11.0% during the forecast period. The disorder is associated with melancholic clinical features, abnormal neural activity, bipolarity, inflammatory system activation, neurotransmitter dysfunction, and high traumatic load. Fortune Business Insights™ mentioned this in a report titled “Treatment-Resistance...

BASF Environmental Catalyst and Metal Solutions (ECMS) signs agreement to acquire Arc Metal AB in Sweden

Written by Customer Service on December 11, 2023. Posted in Mergers And Acquisitions.

Acquisition adds smelting capability to serve spent automotive catalyst customers in Europe, Middle East and Africa Complements ECMS recycling operations and global precious metal services Broadens range of materials that can be processed by ECMS Closing of transaction expected in early first quarter 2024 ISELIN, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) — BASF Environmental Catalyst and Metal Solutions (ECMS) has signed an agreement to purchase the assets of Arc Metal AB in Hofors, Sweden. The company currently conducts toll smelting and processing of spent automotive catalyst, among other services, and will further complement ECMS’s existing global precious metal recycling operations in Cinderford, UK, Seneca and Spartanburg, South Carolina, and Caldwell, Texas, USA. The closing of the transaction is expected early in the first...

Collective Audience Appoints Technology Visionary, Investor, and Executive Leader, Peter Bordes, as Chief Executive Officer

Written by Customer Service on December 11, 2023. Posted in Public Companies.

Peter Bordes Collective Audience Appoints Technology Visionary, Investor, and Executive Leader, Peter Bordes, as Chief Executive Officer NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) — Collective Audience, Inc. (Nasdaq: CAUD), a leading innovator of audience based performance advertising and media solutions, has appointed Peter Bordes as chief executive officer, succeeding Brent Suen who will continue to serve on the board of directors. A lifelong entrepreneur, operator and venture investor, Bordes brings to the company more than 30 years of executive and board experience leading private and public companies across the AdTech, media, AI, fintech and technology sectors. His career and investing have focused on innovation and disruptive technologies that drive digital transformation. “I have followed Peter’s career since the early...

Alto Ingredients, Inc. Publishes Sustainability Summary

Written by Customer Service on December 11, 2023. Posted in Public Companies.

PEKIN, Ill., Dec. 11, 2023 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols and essential ingredients, has published its inaugural Sustainability Summary outlining the company’s performance in key areas, such as environmental, health and safety, along with the strategy and vision for advancements in sustainability, responsible sourcing, and risk management. “As a renewables company, we are dedicated to implementing sustainable best practices that are good for our business, our stakeholders and our planet,” said Bryon McGregor, President and CEO of Alto Ingredients. “From integrating innovative practices at our facilities that ensure optimal efficiency, contributing to a lower carbon footprint with our ethanol fuel, and to giving back to the community through...

KH Group’s has made follow-on investment in Indoor

Written by Customer Service on December 11, 2023. Posted in Public Companies.

KH Group PlcPress Release 11 December 2023 at 3:30 pm EET KH Group’s has made follow-on investment in Indoor KH Group together with other shareholders of Indoor Group Holding Oy (“Indoor”) have made combined EUR 2.8 million follow-on investments in Indoor. These follow-on investments were made by subordinated loan. Loan proceeds are used to repay interest-bearing debts. The follow-on investments strengthen Indoor’s balance sheet accordingly. KH Group Plc’s share of the subordinated loan in Indoor is EUR 2.1 million. This arrangement has been finalised today and will not affect the ownership structure in Indoor Group Holding Oy. KH GROUP PLC FURTHER INFORMATION: CEO Lauri Veijalainen, puh. +358 46 876 1648 DISTRIBUTION: Major mediawww.khgroup.com Sievi Capital is now a conglomerate with a new name KH Group. Our four business areas are...

Allison Abraham Retires as Co-Chair and Member of the Beyond, Inc. Board of Directors

Written by Customer Service on December 11, 2023. Posted in Public Companies.

Marcus Lemonis will serve as the Chairman of the Board MIDVALE, Utah, Dec. 11, 2023 (GLOBE NEWSWIRE) — Beyond, Inc., (NYSE: BYON) (“Beyond” or the “Company”), the parent company of online furniture and home furnishings retailer Bed Bath & Beyond, formerly known as Overstock, today announced that, on December 10, 2023, Allison H. Abraham notified the Board of Directors of Beyond (“the Board”) of her decision to retire. As part of that transition, Ms. Abraham resigned as a Director of the Company, effective immediately. Marcus Lemonis will transition to the role of Chairman of the Company’s Board of Directors. Ms. Abraham said, “I thank the Board, management, and rest of the Beyond family for their support over the years. It has been an honor to work for the Company and represent our shareholders for more than two decades....

FDA Accepts for Review Resubmitted NDA for TransCon PTH (Palopegteriparatide) in Adult Patients with Hypoparathyroidism

Written by Customer Service on December 11, 2023. Posted in Public Companies.

– PDUFA goal date is May 14, 2024 COPENHAGEN, Denmark, Dec. 11, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has accepted for review the Company’s resubmitted New Drug Application (NDA) for TransCon PTH (palopegteriparatide) for the treatment of adult patients with hypoparathyroidism. The agency considered the resubmission a complete, class 2 response and set a Prescription Drug User Fee Act (PDUFA) goal date of May 14, 2024. In the United States, TransCon PTH (palopegteriparatide) is an investigational prodrug of parathyroid hormone (PTH [1-34]) for adult patients with hypoparathyroidism. “We are pleased that the FDA can continue its review of TransCon PTH and look forward to working with the agency during its review,” said Jan Mikkelsen, President...

Coherus Announces Updated NCCN Clinical Practice Guidelines Positioning LOQTORZI™ (toripalimab-tpzi) as Preferred Category 1 Regimen for First-Line Treatment of Cancer of the Nasopharynx

Written by Customer Service on December 11, 2023. Posted in Public Companies.

– NCCN Guidelines recommend LOQTORZI as the only Preferred Category 1 treatment option in first-line treatment for adults with metastatic or recurrent locally advanced NPC in combination with chemotherapy; LOQTORZI monotherapy also recommended as the only preferred regimen in subsequent lines of therapy – -– LOQTORZI is the first and only FDA-approved treatment for recurrent or metastatic NPC in all lines of therapy– REDWOOD CITY, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) announced today that the National Comprehensive Cancer Network (NCCN) has updated the clinical practice guidelines for nasopharyngeal carcinoma (NPC) to include LOQTORZI™ (toripalimab-tpzi) as a preferred, category 1 first-line treatment option for adults with metastatic or recurrent locally advanced NPC...

RespireRx Pharmaceuticals Inc. Announces Agreement with Ponto Ventures to Drive Business Development with Will Clodfelter as RespireRx Part-Time Senior VP of Business Development

Written by Customer Service on December 11, 2023. Posted in Public Companies.

Glen Rock, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”), a biopharmaceutical company focused on the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce that, on December 6, 2023, it has entered into an agreement with Ponto Ventures LLC providing for Will Clodfelter to serve as RespireRx’s Senior Vice President of Business Development on a part-time basis. Mr. Clodfelter will initially lead the business development efforts with respect to dronabinol, the lead asset of ResolutionRx Ltd, a wholly-owned Australian subsidiary of the Company. Mr. Clodfelter will collaborate with Jeff Eliot Margolis, the Company’s Senior Vice President, Chief Financial Officer,...

Day: December 11, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice